UTI. Urinary tract infection, site not specified
Conditions
Interventions
Intervention 1: Intervention group ESBL: Each 48 hours of amikacin is given 3mg / kg / Q48 hours for 7 days, and then treatment of Ofloxacin 300 mg twice daily for 7 days is continued. Intervention 2:
Sponsors
Kurdistan university of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with symptoms of burning up urine Patients with frequent urinary symptoms Patients with urinary symptoms and fever
Exclusion criteria
Exclusion criteria: Use of antibiotics over the last week Stage I and above CKD pregnancy septic shock use of immuno suppressive drugs Increased patient creatinine by more than 3 or more than 50% relative to the original creatinine during treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary tract infection(UTI). Timepoint: 7 days after the start of treatment, intravenous and oral treatment phase (7 days. Method of measurement: Urine analysis and urina culture.;Clinical symptoms of UTI. Timepoint: 48 hours and 1 week after the end of therapy with intravenous and oral treatment. Method of measurement: By patient symptoms and clinical findings. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse Drug Reactions. Timepoint: 48 hours and 1 week after treatment and at the end of intravenous and oral treatment. Method of measurement: Clinical symptoms and examination findings, laboratory. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contacthero azizzadeh
Kurdistan University of Medical Sciences
Outcome results
None listed